EUVIMEDEUVIMED entdecken
Open Access

H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus

Yi-Nong Chen, Ying-Lin Chen, Wan-Ming Chen, Mingchih Chen, Ben-Chang Shia, Jenq-Yuh Ko, Szu-Yuan Wu

Oncology Research · 2023 · 31 (1) · 23-34

DOI: 10.32604/or.2022.028449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2023. Verfasst von Yi-Nong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Head and Neck NeoplasmsHumansHistamine Antagonists

Stichwörter der Autor:innen

H1-AntihistamineHead and neck cancerIncidenceIncidence rateType 2 diabetes

Substanzen

Histamine Antagonists

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
  • Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.
  • Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan.
  • Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.

Zitieren

APA

Chen, Y. N., Chen, Y. L., Chen, W. M., Chen, M., Shia, B. C., Ko, J. Y., & Wu, S. Y. (2023). H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus. Oncology Research, 31(1), 23-34. https://doi.org/10.32604/or.2022.028449

Vancouver

Chen YN, Chen YL, Chen WM, Chen M, Shia BC, Ko JY, et al. H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus. Oncology Research. 2023;31(1):23-34. doi:10.32604/or.2022.028449

BibTeX
@article{Chen2023,
  author = {Chen, Yi-Nong and Chen, Ying-Lin and Chen, Wan-Ming and Chen, Mingchih and Shia, Ben-Chang and Ko, Jenq-Yuh and Wu, Szu-Yuan},
  title = {H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus},
  journal = {Oncology Research},
  year = {2023},
  volume = {31},
  number = {1},
  pages = {23--34},
  doi = {10.32604/or.2022.028449}
}
Kostenlos starten →